Pediatrix Medical Group, Inc.
Financials
Valuation Metrics
Pediatrix Medical Group, Inc.'s Market Cap is $2.52B. At end of 2025 it was $1.81B. Ranked #1858 of 3,115 in US market (top 60%), #1180 of 1,643 on NYSE (top 72%), #113 of 203 in Health Care Equipment & Services (top 56%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.52B | US#1,858/3,115 Sec#113/203 |
| Revenue | $1.96B | US#1,438/3,115 Sec#91/203 |
| Net Income | $150M | US#1,351/3,115 Sec#65/203 |
| Total Assets | $2.14B | US#2,036/3,115 Sec#101/203 |
| Net Assets | $850M | US#1,852/3,115 Sec#97/203 |
| Employees | 4,280 | US#1,308/3,115 Sec#93/203 |
| Value | ||
| P/E | 16.81x | US#652/3,115 Sec#9/203 |
| P/B | 2.97x | US#1,636/3,115 Sec#81/203 |
| P/S | 1.29x | US#850/3,115 Sec#55/203 |
| EV/EBITDA | 11.29x | US#829/3,115 Sec#23/203 |
| FCF Yield | 8.32% | US#621/3,115 Sec#24/203 |
| Profitability | ||
| ROE | 17.67% | US#585/3,115 Sec#27/203 |
| ROA | 7.02% | US#632/3,115 Sec#36/203 |
| Op. Margin | 11.40% | US#1,448/3,115 Sec#64/203 |
| Revenue Growth | 1.91% | US#2,168/3,115 Sec#162/203 |
| Earnings Growth | -7.46% | US#436/3,115 Sec#20/203 |
| Financial Health | ||
| Debt Ratio | 151.81% | US#1,431/3,115 Sec#132/203 |
| Total Debt | $612M | US#1,760/3,115 Sec#97/203 |
| FCF | $210M | US#1,312/3,115 Sec#76/203 |
| Cash | $312M | US#1,442/3,115 Sec#83/203 |
| Current Ratio | 1.28x | US#1,866/3,115 Sec#163/203 |
| Net Debt/EBITDA | 1.20x | US#1,064/3,115 Sec#62/203 |
| Performance | ||
| 1Y Return | 81.05% | US#358/3,115 Sec#37/203 |
| 1M Return | 18.31% | US#489/3,115 Sec#54/203 |
| From 52W High | -1.11% | US#291/3,115 Sec#40/203 |
| 1Y MDD | -23.65% | US#883/3,115 Sec#29/203 |
| Trading | ||
| Volume | 856,732 shares | US#2,090/3,115 Sec#148/203 |
| Trading Value | $26M | US#2,106/3,115 Sec#148/203 |
| Per Share | ||
| EPS | $1.83 | US#1,294/3,115 Sec#65/203 |
| BPS | $10.35 | US#1,791/3,115 Sec#100/203 |
Company Info
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.